Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:10762047rdf:typepubmed:Citationlld:pubmed
pubmed-article:10762047lifeskim:mentionsumls-concept:C0009968lld:lifeskim
pubmed-article:10762047lifeskim:mentionsumls-concept:C0028013lld:lifeskim
pubmed-article:10762047lifeskim:mentionsumls-concept:C0441655lld:lifeskim
pubmed-article:10762047lifeskim:mentionsumls-concept:C2919063lld:lifeskim
pubmed-article:10762047lifeskim:mentionsumls-concept:C1704241lld:lifeskim
pubmed-article:10762047lifeskim:mentionsumls-concept:C1533691lld:lifeskim
pubmed-article:10762047lifeskim:mentionsumls-concept:C0360390lld:lifeskim
pubmed-article:10762047pubmed:issue7lld:pubmed
pubmed-article:10762047pubmed:dateCreated2000-8-17lld:pubmed
pubmed-article:10762047pubmed:abstractTextIsonicotinoylhydrazones 1, obtained by the primary antituberculous agent Isoniazid, have been used as monoanionic ligands (L) to prepare copper(II) 2 and nickel(II) 3 octahedral complexes of stoichiometry [MeL2(H2O)2]. Their antimycobacterial in vitro activity was evaluated against Mycobacterium tuberculosis H37Rv in comparison with the ligands. Complexes 2a, 2b, 2f, 3b, 3d and 3g displayed MIC values < or = 0.2 microg/mL.lld:pubmed
pubmed-article:10762047pubmed:languageenglld:pubmed
pubmed-article:10762047pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10762047pubmed:citationSubsetIMlld:pubmed
pubmed-article:10762047pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10762047pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10762047pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10762047pubmed:statusMEDLINElld:pubmed
pubmed-article:10762047pubmed:monthAprlld:pubmed
pubmed-article:10762047pubmed:issn0960-894Xlld:pubmed
pubmed-article:10762047pubmed:authorpubmed-author:VigoritaM GMGlld:pubmed
pubmed-article:10762047pubmed:authorpubmed-author:MonforteFFlld:pubmed
pubmed-article:10762047pubmed:authorpubmed-author:RotondoEElld:pubmed
pubmed-article:10762047pubmed:authorpubmed-author:OttanàRRlld:pubmed
pubmed-article:10762047pubmed:authorpubmed-author:MaccariRRlld:pubmed
pubmed-article:10762047pubmed:authorpubmed-author:BottariBBlld:pubmed
pubmed-article:10762047pubmed:issnTypePrintlld:pubmed
pubmed-article:10762047pubmed:day3lld:pubmed
pubmed-article:10762047pubmed:volume10lld:pubmed
pubmed-article:10762047pubmed:ownerNLMlld:pubmed
pubmed-article:10762047pubmed:authorsCompleteYlld:pubmed
pubmed-article:10762047pubmed:pagination657-60lld:pubmed
pubmed-article:10762047pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:10762047pubmed:meshHeadingpubmed-meshheading:10762047...lld:pubmed
pubmed-article:10762047pubmed:meshHeadingpubmed-meshheading:10762047...lld:pubmed
pubmed-article:10762047pubmed:meshHeadingpubmed-meshheading:10762047...lld:pubmed
pubmed-article:10762047pubmed:meshHeadingpubmed-meshheading:10762047...lld:pubmed
pubmed-article:10762047pubmed:meshHeadingpubmed-meshheading:10762047...lld:pubmed
pubmed-article:10762047pubmed:meshHeadingpubmed-meshheading:10762047...lld:pubmed
pubmed-article:10762047pubmed:year2000lld:pubmed
pubmed-article:10762047pubmed:articleTitleIsoniazid-related copper(II) and nickel(II) complexes with antimycobacterial in vitro activity. Part 9.lld:pubmed
pubmed-article:10762047pubmed:affiliationDipartimento Farmaco-chimico, Facoltà di Farmacia, Università di Messina, Italy.lld:pubmed
pubmed-article:10762047pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:10762047pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...http://linkedlifedata.com/r...pubmed-article:10762047lld:chembl
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:10762047lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:10762047lld:pubmed